Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

Similar articles for PubMed (Select 21842427)

1.

The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis.

Sharma D, Morrison G, Joseph F, Purewal TS, Weston PJ.

Diabetologia. 2011 Nov;54(11):2768-70. doi: 10.1007/s00125-011-2282-6. Epub 2011 Aug 14.

PMID:
21842427
3.
4.

Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years.

Jakisch BI, Wagner VM, Heidtmann B, Lepler R, Holterhus PM, Kapellen TM, Vogel C, Rosenbauer J, Holl RW; German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy.

Diabet Med. 2008 Jan;25(1):80-5. doi: 10.1111/j.1464-5491.2007.02311.x.

PMID:
18199134
5.

Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.

Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M.

Diabet Med. 2010 Mar;27(3):339-47. doi: 10.1111/j.1464-5491.2009.02925.x.

PMID:
20536498
6.

Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.

Cohen ND, Hong ES, Van Drie C, Balkau B, Shaw J.

Diabetes Technol Ther. 2013 Jul;15(7):544-9. doi: 10.1089/dia.2012.0331. Epub 2013 Apr 25.

PMID:
23617252
7.

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.

Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group.

Diabet Med. 2006 Feb;23(2):141-7.

PMID:
16433711
8.

Effects of a novel short-term continuous subcutaneous insulin infusion program evaluated by continuous glucose monitoring on young adult type 1 diabetic patients in Taiwan.

Lin CH, Huang CH, Tsai JS, Hsieh SH, Sun JH, Huang BY, Huang MJ, Huang YY.

Endocr J. 2011;58(10):835-40. Epub 2011 Aug 9.

9.

Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.

Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J.

Diabetes Technol Ther. 2007 Aug;9(4):339-47.

PMID:
17705689
11.

Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?

Shalitin S, Lahav-Ritte T, Lebenthal Y, Devries L, Phillip M.

Diabetes Technol Ther. 2012 May;14(5):389-97. doi: 10.1089/dia.2011.0267. Epub 2012 Jan 27.

PMID:
22283639
13.

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.

Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A.

Diabet Med. 2008 Mar;25(3):326-32. doi: 10.1111/j.1464-5491.2007.02365.x.

PMID:
18307459
14.
15.

Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.

Moreno-Fernandez J, Gomez FJ, Gazquez M, Pedroche M, García-Manzanares A, Tenias JM, Benito P, Gomez IR.

Diabetes Technol Ther. 2013 Jul;15(7):596-600. doi: 10.1089/dia.2013.0033. Epub 2013 Apr 30.

PMID:
23631604
16.

Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion.

Nixon R, Folwell R, Pickup JC.

Diabet Med. 2014 Oct;31(10):1174-7. doi: 10.1111/dme.12486. Epub 2014 May 20.

PMID:
24804864
17.

Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.

Willi SM, Planton J, Egede L, Schwarz S.

J Pediatr. 2003 Dec;143(6):796-801.

PMID:
14657831
19.

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.

Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A.

Diabetologia. 2008 Jun;51(6):941-51. doi: 10.1007/s00125-008-0974-3. Epub 2008 Mar 20. Review.

PMID:
18351320
20.

Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service.

Giménez M, Conget I, Jansà M, Vidal M, Chiganer G, Levy I.

Diabet Med. 2007 Dec;24(12):1419-23. Epub 2007 Oct 17.

PMID:
17941861
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk